PROSTATE BIOPSY INFORMATION FOR THE TRUST
Case reference FOI2026/06488
Received 30 October 2026
Published 10 November 2026
Request
I am writing to request information under the Freedom of Information Act 2000 regarding prostate biopsy procedures, ultrasound equipment and MRI–ultrasound fusion biopsy technology currently used within your NHS Trust.
I would be grateful if you could provide the following information, ideally broken down by individual hospital or site where applicable.
1. Prostate Biopsy Equipment
a. Which hospitals within your Trust currently perform prostate biopsy procedures?
b. What make and model of ultrasound system is routinely used for prostate biopsies at each site (e.g. BK Medical, Fujifilm/Hitachi, Philips, GE Healthcare)?
c. In what year were these systems purchased or first installed?
d. Are the ultrasound systems owned outright, leased or provided under another arrangement?
2. MRI–Ultrasound Fusion Biopsy
a. Does the Trust currently perform MRI–ultrasound fusion-guided prostate biopsies?
b. If software fusion is not currently available, is there a plan to introduce it within the next 12–24 months?
3. Prostate Biopsy Activity and Volumes
For the most recent complete 12-month period for which data is available:
a. How many prostate biopsy procedures were performed across the Trust, broken down by hospital?
b. Approximately what proportion of transperineal biopsies are performed under local anaesthetic versus general anaesthetic?
c. How many prostate biopsy sessions or dedicated biopsy lists are typically scheduled per week at each site?
d. Are prostate biopsies undertaken primarily by consultant urologists, specialist nurses or other healthcare professionals?
4. Equipment Replacement and Future Plans
a. Are there any planned replacements or upgrades of existing prostate biopsy ultrasound equipment within the next 24 months?
b. Is the Trust currently considering, evaluating or tendering for new prostate biopsy or MRI fusion technology?
c. Where recorded, when do existing equipment maintenance, lease or service agreements expire?
5. Departmental Responsibility
a. Which department is responsible for managing prostate biopsy equipment and associated procurement?
b. Please provide the job titles or departmental roles responsible for clinical evaluation, equipment selection and procurement of prostate biopsy systems.
Response
1. Prostate Biopsy Equipment
a. Which hospitals within your Trust currently perform prostate biopsy procedures? Churchill Hospital
b. What make and model of ultrasound system is routinely used for prostate biopsies at each site (e.g. BK Medical, Fujifilm/Hitachi, Philips, GE Healthcare)?
GE Healthcare (BK Medical) BK Specto
c. In what year were these systems purchased or first installed?
2026
d. Are the ultrasound systems owned outright, leased or provided under another arrangement?
Owned
2. MRI–Ultrasound Fusion Biopsy
a. Does the Trust currently perform MRI–ultrasound fusion-guided prostate biopsies?
No
b. If software fusion is not currently available, is there a plan to introduce it within the next 12–24 months?
No
3. Prostate Biopsy Activity and Volumes
For the most recent complete 12-month period for which data is available:
a. How many prostate biopsy procedures were performed across the Trust, broken down by hospital?
All at Churchill Hospital, 935
b. Approximately what proportion of transperineal biopsies are performed under local anaesthetic versus general anaesthetic?
Approx 5% of all biopsies (50 in last 12 months) are transperineal under general anaesthetic, the rest are under local anaesthetic (739 transperineal & 146 transrectal)
c. How many prostate biopsy sessions or dedicated biopsy lists are typically scheduled per week at each site?
Outpatient sessions: 6-7. General anaesthetic ad hoc as required on theatre lists
d. Are prostate biopsies undertaken primarily by consultant urologists, specialist nurses or other healthcare professionals?
In outpatients mostly nurse practitioners plus one clinic for urology pelvic fellow/registrar. For general anaesthetics – consultant/pelvic fellow/registrar
4. Equipment Replacement and Future Plans
a. Are there any planned replacements or upgrades of existing prostate biopsy ultrasound equipment within the next 24 months?
No
b. Is the Trust currently considering, evaluating or tendering for new prostate biopsy or MRI fusion technology?
No
c. Where recorded, when do existing equipment maintenance, lease or service agreements expire?
Current machine delivered May 2026. Device under warranty until 15/04/2027
5. Departmental Responsibility
a. Which department is responsible for managing prostate biopsy equipment and associated procurement?
Procurement, clinical engineering, urology outpatients (day to day)
b. Please provide the job titles or departmental roles responsible for clinical evaluation, equipment selection and procurement of prostate biopsy systems.
Clinical input from Diagnostic Advanced Nurse Practitioner/Prostate Clinical Lead/Department input from Directorate Manager/Procurement Business Partner/Clinical Engineering MDR team
Documents
This is Oxford University Hospitals NHS Foundation Trust's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.